96806 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses; RNA viruses; Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus human T-cell leukaemia-lymphoma virus; Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV; HIV-1 ; HIV-2 Regulatory proteins, e.g. tat, nef, rev, vif, vpu, vpr, vpt, vpx
DELIVERY OF HETEROLOGOUS PROTEINS
#2ARTIFICIAL PROTEIN AND USES THEREOF
#3METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#4METHODS AND CONSTRUCTS FOR PRODUCTION OF LENTIVIRAL VECTOR
#5Targeting Nuclear Speckles and DNA Speckle Association
#6IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPY
#7Compositions and methods for treating SARS-CoV-2 infections
#8Expression systems comprising nucleic acids encoding HIV-1 protease cleavage site polypeptides
#9Chloride salt of TAT-NR2B9C
#10Multivalent HIV vaccine boost compositions and methods of use
#11CELL PENETRATING PEPTIDES
#12HIV/SIV Nef fusion proteins for exosome targeted expression
#13Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
#14Methods and constructs for production of lentiviral vector
#15EXOSOME TARGETING OF CD4+ EXPRESSING CELLS
#16Chloride salt of TAT-NR2B9C
#17Methods of inducing an immune response against HIV-1 utilizing nucleic acids encoding polypeptides containing HIV-1 protease cleavage sites
#18CELL PENETRATING PEPTIDES
#19Compositions and methods for regulating blood pressure
#20COMPOSITIONS AND METHODS FOR EXOSOME TARGETED EXPRESSION
#21Method for preparing cells expressing Nef-fusion proteins associated with exosomes
#22TAU PEPTIDES, METHODS OF MAKING, AND METHODS OF USING
#23Nanoparticles carrying immunogenic peptides targeting HIV-1 protease cleavage sites
#24Chloride salt of TAT-NR2B9c
#25Recombinant HCMV and RHCMV vectors and uses thereof
#26Method of inducing an immune response by administering exosomes comprising Nef-fusion proteins
#27Methods of inducing an immune response against HIV by administering immunogenic peptides obtained from protease cleavage sites
#28Treatment of Inflammation, Autoimmune, and Neurodegenerative Disorders with Immunosuppressive Tat Derivative Polypeptides
#29Compositions and methods for regulating blood pressure
#30Compositions and methods for exosome targeted expression
#31Chloride salt of TAT-NR2B9c
#32Recombinant HCMV and RHCMV vectors and uses thereof
#33Immunosuppressive Tat derivative polypeptides
#34Method of purifying HIV/SIV Nef from exosomal fusion proteins
#35Method for the detection of HIV-1 antibodies utilizing a peptide containing a novel gp41 epitope
#36Recombinant HCMV and RHCMV vectors and uses thereof
#37Method of improving immune function in HIV-infected subjects on HAART by administering HIV-1 TAT
#38Process for the production of biologically active HIV-1 tat protein
#39Methods for the detection of HIV-1-specific antibodies employing GP41 polypeptides
#40COMPOSITIONS AND METHODS FOR THE DETECTION OF HIV-1/HIV-2 INFECTION
#41Methods for the detection of HIV-1 antibodies employing polypeptides obtained from gag P6 protein
#42Mutated HIV Nef for modulating immunity
#43Compositions and methods for treating SARS-CoV-2 infections
#44Tat complexes, and vaccines comprising them